Physician profile
Karen E Martinez
NPI 1417430927
$1,241.10
in general payments reported to CMS, 2019-2025
10 companies · $440 in 2025
The $440 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $190 · 2022: $254 · 2023: $249 · 2024: $107 · 2025: $440.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $797.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $796.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| W. L. Gore & Associates, INC. | $227.31 | 2021-2025 | Gore Excluder Thoracoabdominal Branch Endoprosthesis, Excluder Conformable Aaa Endoprosthesis With Active Control, Gore Tag Thoracic Branch Endoprosthesis |
| Edwards Lifesciences Corporation | $184.85 | 2021-2023 | |
| Angiodynamics, INC. | $181.98 | 2025 | Auryon Laser System 100-120 Vac |
| Silk Road Medical, INC. | $181.09 | 2023 | Enroute Transcarotid Stent, Enroute Transcarotid Neuroprotection System |
| Medtronic, INC. | $143.98 | 2022 | |
| Endologix LLC | $130.15 | 2025 | Endocross Device, Torus Stent Graft System |
| Tactile Systems Technology INC | $90.46 | 2021-2025 | Flexitouch Plus, Entre Plus, Nimbl |
| Abbott Laboratories | $47.92 | 2025 | Jot Dx |
| Amgen INC. | $33.62 | 2024 | Repatha |
| Janssen Pharmaceuticals, INC | $19.74 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Karen Martinez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.